A Study to Assess the Ability of Eltrombopag to Induce Sustained Remission in Subjects With ITP (Q63811721)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
A Study to Assess the Ability of Eltrombopag to Induce Sustained Remission in Subjects With ITP
clinical trial

    Statements

    TAPER (English)
    0 references
    A Phase II, Open-label, Prospective, Single-arm, Study to Assess Ability of Eltrombopag to Induce Sustained Remission in Subjects With ITP Who Are Refractory or Relapsed After First-line Steroids (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    2 November 2018
    0 references
    13 May 2022
    0 references
    101
    0 references
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit